IRIS

Sfoglia per Rivista  

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 30 a 49 di 102
Titolo Data di pubblicazione Autore(i) File
Editorial: to facitinib and biologics for moderate-to-severe ulcerative colitis-what is best in class? Authors' reply 1-gen-2018 Bonovas, S; Lytras, T; Nikolopoulos, G; Peyrin-Biroulet, L; Danese, S
Editorial: withdrawal of anti TNF-alpha - are we ready for biological therapy cycling? 1-gen-2021 Pugliese, D; Armuzzi, A
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG-IBD LIVE study 1-gen-2022 Pugliese, Daniela; Privitera, Giuseppe; Crispino, Federica; Mezzina, Nicolò; Castiglione, Fabiana; Fiorino, Gionata; Laterza, Lucrezia; Viola, Anna; Bertani, Lorenzo; Caprioli, Flavio; Cappello, Maria; Barberio, Brigida; Ricci, Chiara; Balestrieri, Paola; Daperno, Marco; Pluchino, Dario; Rizzello, Fernando; Scribano, Maria Lia; Sablich, Renato; Pastorelli, Luca; Manguso, Francesco; Variola, Angela; Di Sario, Antonio; Grossi, Laurino; Armuzzi, Alessandro; Null, Null
Efficacy and safety of tofacitinib dose de-escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open 1-gen-2020 Sands, Be; Armuzzi, A; Marshall, Jk; Lindsay, Jo; Sandborn, Wj; Danese, S; Panes, J; Bressler, B; Colombel, Jf; Lawendy, N; Maller, E; Zhang, Hy; Chan, G; Salese, L; Tsilkos, K; Marren, A; Su, Cy
Efficacy of a multistep strategy for Helicobacter pylori eradication 1-gen-2000 Gasbarrini, A; Ojetti, V; Armuzzi, A; Branca, G; Canducci, F; Torre, Es; Candelli, M; Pastorelli, A; Anti, M; Fedeli, G; Fadda, G; Pola, P; Gasbarrini, G
Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis 1-gen-2006 Zocco, Ma; Dal Verme, Lz; Cremonini, F; Piscaglia, Ac; Nista, Ec; Candelli, M; Novi, M; Rigante, D; Cazzato, Ia; Ojetti, V; Armuzzi, A; Gasbarrini, G; Gasbarrini, A
Efficacy of two one-week rabeprazole/levofloxacin-based triple therapies for Helicobacter pylori infection 1-gen-2000 Cammarota, G; Cianci, R; Cannizzaro, O; Cuoco, L; Pirozzi, G; Gasbarrini, A; Armuzzi, A; Zocco, Ma; Santarelli, L; Arancio, F; Gasbarrini, G
Epithelial cell proliferation of the colonic mucosa in diverticular disease: a case-control study 1-gen-2005 Morini, S; Hassan, Cesare; Zullo, A; De Francesco, V; Burattini, O; Margiotta, M; Panella, C; Ierardi, E.
Five-day regimens containing ranitidine bismuth citrate plus high-dose clarithromycin and either amoxycillin or tinidazole for Helicobacter pylori infection 1-gen-2000 Cammarota, G; Cannizzaro, O; Ojetti, V; Cianci, R; Pastorelli, A; Armuzzi, A; Gentiloni, N; Gasbarrini, A; Pirozzi, G; Gasbarrini, G
Heat shock protein 47 is a new candidate molecule as anti-fibrotic treatment of Crohn's disease: authors' reply 1-gen-2010 Szabo, H; Fiorino, G; Danese, S
Helicobacter pylori eradication with proton pump inhibitor-based triple therapies and re-treatment with ranitidine bismuth citrate-based triple therapy 1-gen-1999 Rinaldi, V; Zullo, A; De Francesco, V; Hassan, Cesare; Winn, S; Stoppino, V; Faleo, D; Attili, Af
High efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinoma 1-gen-2018 Persico, M; Aglitti, A; Aghemo, A; Rendina, M; Lleo, A; Ciancio, A; Di Marco, V; Lampertico, P; Brunetto, Mr; Zuin, M; Andreone, P; Villa, E; Troshina, G; Calvaruso, V; Degasperi, E; Coco, B; Giorgini, A; Conti, F; Di Leo, A; Marzi, L; Boccaccio, V; Bollani, S; Maisonneuve, P; Bruno, S
High eradication rates of Helicobacter pylori with a new sequential treatment 1-gen-2003 Zullo, A; Vaira, D; Vakil, N; Hassan, Cesare; Gatta, L; Ricci, Carlo Antonio; De Francesco, V; Menegatti, M; Tampieri, A; Perna, Francesco; Rinaldi, V; Perri, Fabio; Papadìa, C; Fornari, F; Pilati, S; Mete, Ls; Merla, Antonio; Potì, R; Marinone, G; Savioli, A; Campo, Sma; Faleo, D; Ierardi, E; Miglioli, M; Morini, S.
High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study 1-gen-2005 Zullo, A; Gatta, L; De Francesco, V; Hassan, Cesare; Ricci, Carlo Antonio; Bernabucci, V; Cavina, Mariateresa; Ierardi, E; Morini, S; Vaira, D.
Implications of PNPLA3 polymorphism in chronic hepatitis C patients receiving peginterferon plus ribavirin 1-gen-2012 Valenti, L; Aghemo, A; Stattermayer, Af; Maggioni, P; De Nicola, S; Motta, Bm; Rumi, Mg; Dongiovanni, P; Ferenci, P; Colombo, M; Fargion, S
Increased carotid intima-media thickness in patients with inflammatory bowel disease 1-gen-2005 Papa, A; Santoliquido, A; Danese, S; Covino, M; Di Campli, C; Urgesi, R; Grillo, A; Guglielmo, S; Tondi, P; Guidi, L; De Vitis, I; Fedeli, G; Gasbarrini, G; Gasbarrini, A
Induction of clinical and colonoscopic remission of mild-to-moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies 1-gen-2015 Sandborn, Wj; Danese, S; D'Haens, G; Moro, L; Jones, R; Bagin, R; Huang, M; Ballard, Ed; Masure, J; Travis, S
Inflammatory bowel disease: estimates from the global burden of disease 2017 study 1-gen-2020 Piovani, D; Danese, S; Peyrin-Biroulet, L; Bonovas, S
Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up 1-gen-2007 Kohn, A; Daperno, M; Armuzzi, A; Cappello, M; Biancone, L; Orlando, A; Viscido, A; Annese, V; Riegler, G; Meucci, G; Marrollo, M; Sostegni, R; Gasbarrini, A; Peralta, S; Prantera, C
Influenza A (H1N1)v infection in patients with inflammatory bowel disease: a case series 1-gen-2011 Rahier, Jf; Papay, P; Salleron, J; Sebastian, S; Ellul, P; Teich, N; Fiorino, G; Blaha, B; GARCIA-SANCHEZ, V; Haas, T; VAN GOSSUM, A; Abitbol, V; Yazdanpanah, Y; Chaparro, Mc
Mostrati risultati da 30 a 49 di 102
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile